Home1
Psychological tests2
Drug Attitude Inventory (DAI-30)3

Drug Attitude Inventory (DAI-30) Test

Designed for people reflecting on their experience with prescribed treatment, the Drug Attitude Inventory (DAI-30) Test contains 30 true-or-false questions and takes about 6 minutes. Its result highlights positive and negative responses to medication, helping respondents reflect on willingness to follow medical recommendations and understand their overall profile.

Questions: 306 minutes

Drug Attitude Inventory (DAI-30) Test: sample question card

October 2, 2025October 2, 2025Material has been updatedOctober 2, 2025Material has been published

37,306 views

4,119 completions

3,370 likes

Daniel Hall Psychologist · Test reviewer

3,370 likes

Scale Explorer

How the Scales are Structured

Negative AttitudeNA

Counts negative attitudes toward medication that are associated with non-adherence or resistance to treatment recommendations.

example score4/15

4/15Low negative attitudeexample score

0 – 5Low negative attitude

6 – 10Moderate negative attitude

11 – 15High negative attitude

A score of 4 falls in the low negative attitude range, suggesting relatively few negative or resistant views about the prescribed medication regimen.

PositiveP

Measures the number of positive responses indicating a cooperative, medication-supportive attitude toward treatment.

example score8/15

8/15Moderate positivityexample score

0 – 5Low positivity

6 – 10Moderate positivity

11 – 15High positivity

A score of 8 falls in the Moderate positivity range, suggesting a generally supportive attitude toward treatment with some remaining reservations.

Treatment AttitudeTA

Measures a patient’s overall attitude toward prescribed medication and readiness to follow the treatment plan.

example score-1/15

-1/15Negative attitude / non-complianceexample score

-15 – -1Negative attitude / non-compliance

0 – 15Positive attitude / compliance

A score of -1 falls in the negative attitude range, suggesting slight reluctance or low readiness to follow the prescribed treatment.

just completed the test

DATA-BASED USER COHORTS

Who Usually Takes This Test?

Patients starting medication

41%OF USERS

People newly prescribed psychiatric medication who want to clarify their feelings, worries, or expectations about taking it.

Patients with adherence struggles

34%OF USERS

People who miss doses, stop early, or feel conflicted about treatment and want to understand what drives their resistance.

Clinicians monitoring treatment response

25%OF USERS

Psychiatrists, psychologists, and care teams using a quick check-in to track attitudes toward medication over time and guide conversations.

BASED ON AGGREGATED, ANONYMIZED DATA FROM TENS OF THOUSANDS OF FREUDLY USERS.

Benchmarking

See How You Compare

Once you complete the test, your results are compared with real-world data from people in your country.
Below is a preview of how scores are typically distributed across each scale.

Shaded area — where most people score

Dot — the average

You — your score lands on each curve after the test— your score, after the test

NegativeN

You?

Average5.5

Typical rangeTypical2.7 – 8.3

Possible0 – 15

PositiveP

You?

Average4.6

Typical rangeTypical2.1 – 7

Possible0 – 15

Attitude Toward Treatment ScaleATTS

You?

Average-3.4

Typical rangeTypical-8.1 – 1.3

Possible-15 – 15

Featured On

SAMPLE QUESTIONS

Example Questions From the Test

The purpose of this questionnaire is to understand what people think about treatment and what their treatment experiences have been. Read each statement and decide whether it is true or false for you. If the statement is true or probably true for you, respond “True.” If the statement is false or probably false for you, respond “False.” If you cannot determine with certainty whether a statement is true or false, select the response that is most likely for you. Please note that there are no right or wrong answers on this test; provide your own opinion rather than what you think someone might want to hear. Do not spend too much time on any one item. When responding, consider medications that are necessary to maintain mental health.

- True
- False
- True
- False
- True
- False

These are 3 of the 30 real questions — the rest appear in the test. No sign-up needed to start.

WHAT THE TEST MEASURES

Drug Attitude Inventory (DAI-30) Test - Description and methodology of the test

compliance

psychopathology

People considering how they respond to prescribed medication may use the Drug Attitude Inventory (DAI-30) Test to organize reactions that can affect cooperation with treatment. As a treatment adherence questionnaire, it focuses on perceived benefits, unwanted effects, autonomy, and confidence in continuing care. The result gives respondents a concise profile of attitudes that may support more focused self-reflection.

What This Assessment Explores

In this format, the DAI-30 questionnaire examines reactions to medication and beliefs about ongoing treatment. Statements address benefits, side effects, alertness, concentration, autonomy, social functioning, relapse prevention, and stopping decisions. The result describes treatment attitude and readiness to follow recommendations rather than symptom severity.

The three result types describe these dimensions:

Negative Attitude: 0-15 measures negative responses associated with resistance or unwillingness; Low negative attitude 0-5, Moderate negative attitude 6-10, High negative attitude 11-15.
Positive: 0-15 measures positive responses associated with willingness to cooperate; Low positivity 0-5, Moderate positivity 6-10, High positivity 11-15.
Treatment Attitude: -15-15 measures overall adherence and readiness to follow medical recommendations; Negative attitude / non-compliance -15--1, Positive attitude / compliance 0-15.

Together, the scores show whether resistance or cooperation is more prominent.

Methodology and Evidence Base

Each statement asks respondents to mark whether it is true or false for them, covering beliefs and experiences related to medication and treatment. Items address benefits, side effects, perceived control, and decisions about starting or stopping treatment. The result reports separate counts of positive and negative responses and a total; positive totals indicate compliance, while negative totals indicate non-compliance.

The questionnaire addresses attitudes toward medication and ongoing treatment. The published DAI-30 supplies the conceptual and psychometric reference, with research examining reliability and discriminative validity, while this online form presents the displayed result bands. Research on subjective experiences of antipsychotic medication is relevant to the questionnaire’s attention to perceived benefits and burdens, including how these experiences may relate to treatment outcomes and quality of life.

Interpret the result as a structured snapshot: responses may reflect current treatment experiences, side effects, clinical conversations, social pressure, and self-awareness, and the result can highlight beliefs to explore without showing how consistently treatment is followed in daily life.

Author: Robert P. Awad, Steven C. Hogan, Thomas R. E. Barnes

Literature:

Hogan, T. P., Awad, A. G., & Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13(1), 177-183. 10.1017/S0033291700050182
Awad, A. G., Hogan, T. P., Voruganti, L. N. P., & Heslegrave, R. J. (1995). Patients' subjective experiences on antipsychotic medications: Implications for outcome and quality of life. International Clinical Psychopharmacology, 10(Suppl. 3), 123-132. 10.1097/00004850-199509000-00016

Updated: 2025-10-02